Cytarabine and UCN-01 in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Clinical trial NCT00004263 · COMPLETED
Trial details
- NCT number
- NCT00004263
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 1999-12-01
- Primary completion
- 2007-01-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.